Minnesota SF5187 prohibits health plans from using step therapy protocols for treating neurological conditions.

Minnesota SF5187 aims to prevent health plans from enforcing step therapy protocols for neurological conditions. This bill prohibits health plans from requiring enrollees with neurological conditions to use specific drugs before others, if the drugs are FDA-approved and listed on the plan's formulary. The prohibition takes effect on January 1, 2027, for health plans offered, issued, or renewed on or after that date.

Minnesota SF5187 prohibits health plans from using step therapy protocols for treating neurological conditions.

Minnesota SF5187 aims to prevent health plans from enforcing step therapy protocols for neurological conditions. This bill prohibits health plans from requiring enrollees with neurological conditions to use specific drugs before others, if the drugs are FDA-approved and listed on the plan's formulary. The prohibition takes effect on January 1, 2027, for health plans offered, issued, or renewed on or after that date.